(Yicai Global) Jan. 20 -- Da An Gene's stock price surged today after the Chinese firm said that it has developed a tool to diagnose the type of coronavirus that has caused the third death in Central China's Wuhan. 

Da An Gene's shares [SHE:002030] rose 7.6 percent to CNY12.04 (USD1.76) by lunchtime. 

The product has not been approved by Chinese authorities yet, an insider at the Guangzhou-based firm told Yicai Global today.

Editor: Emmi Laine